Improved junior paediatric prescribing skills after a short e-learning intervention: a randomised controlled trial

Morris Gordon1, Madawa Chandratilake, Paul Baker

  • 1Mary Seacole Building, MS 1.90, Frederick Road Campus, University of Salford, Greater Manchester, M6 6PU, UK. morris@betterprescribing.com

Insights

A new e-learning course significantly improved junior doctors' pediatric prescribing skills and confidence. These positive outcomes for prescribing education were sustained for at least three months.

Area of Science:

  • Medical Education
  • Clinical Pharmacy
  • Pediatric Medicine

Background:

  • Medication errors are prevalent, with junior doctors frequently involved in acute care settings.
  • Paediatric prescribing presents unique challenges, yet educational resources are limited.
  • Developing effective prescribing education for junior doctors is crucial for patient safety.

Purpose of the Study:

  • To develop and evaluate a cost-effective e-learning resource for paediatric prescribing.
  • To enhance the prescribing skills and confidence of junior doctors in paediatric care.
  • To assess the long-term effectiveness of the e-learning intervention.

Main Methods:

  • A non-blinded randomized controlled trial involving 162 junior doctors.
  • Intervention group completed a 1-2 hour e-learning module on paediatric prescribing.
  • Prescribing skills, habits, and confidence were assessed at baseline, and at 1 and 3 months post-intervention.

Main Results:

  • No significant baseline differences in prescribing assessment scores between groups.
  • The e-learning group demonstrated significantly higher prescribing assessment scores post-intervention (79% vs. 63%, p<0.0001).
  • Improved scores and confidence were maintained in the e-learning group at 3 months (p<0.0001).

Conclusions:

  • A brief, low-cost e-learning intervention effectively improved paediatric prescribing skills in junior doctors.
  • The positive effects on prescribing skills and confidence were sustained for at least three months.
  • Educationally sound, low-fidelity e-learning is a viable method for enhancing prescribing education.
Abstract

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...